Conwell Darwin L, Lee Linda S, Yadav Dhiraj, Longnecker Daniel S, Miller Frank H, Mortele Koenraad J, Levy Michael J, Kwon Richard, Lieb John G, Stevens Tyler, Toskes Phillip P, Gardner Timothy B, Gelrud Andres, Wu Bechien U, Forsmark Christopher E, Vege Santhi S
From the *Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH; †Division of Gastroenterology, Hepatology, and Endoscopy, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA; ‡Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA; §Department of Pathology, The Geisel School of Medicine at Dartmouth, Hanover, NH; ║Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL; ¶Department of Radiology, Beth Israel Deaconness Hospital, Harvard Medical School, Boston, MA; #Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN; **Division of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI; ††Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA; ‡‡Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH; §§Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, University of Florida, Gainesville, FL; ║║Department of Gastroenterology, University of Chicago, Chicago, IL; and ¶¶Division of Gastroenterology, Department of Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA.
Pancreas. 2014 Nov;43(8):1143-62. doi: 10.1097/MPA.0000000000000237.
The diagnosis of chronic pancreatitis remains challenging in early stages of the disease. This report defines the diagnostic criteria useful in the assessment of patients with suspected and established chronic pancreatitis. All current diagnostic procedures are reviewed, and evidence-based statements are provided about their utility and limitations. Diagnostic criteria for chronic pancreatitis are classified as definitive, probable, or insufficient evidence. A diagnostic (STEP-wise; survey, tomography, endoscopy, and pancreas function testing) algorithm is proposed that proceeds from a noninvasive to a more invasive approach. This algorithm maximizes specificity (low false-positive rate) in subjects with chronic abdominal pain and equivocal imaging changes. Furthermore, a nomenclature is suggested to further characterize patients with established chronic pancreatitis based on TIGAR-O (toxic, idiopathic, genetic, autoimmune, recurrent, and obstructive) etiology, gland morphology (Cambridge criteria), and physiologic state (exocrine, endocrine function) for uniformity across future multicenter research collaborations. This guideline will serve as a baseline manuscript that will be modified as new evidence becomes available and our knowledge of chronic pancreatitis improves.
慢性胰腺炎在疾病早期的诊断仍然具有挑战性。本报告定义了有助于评估疑似和确诊慢性胰腺炎患者的诊断标准。对所有当前的诊断程序进行了综述,并就其效用和局限性提供了基于证据的陈述。慢性胰腺炎的诊断标准分为确诊、可能或证据不足。提出了一种诊断(逐步;调查、断层扫描、内窥镜检查和胰腺功能测试)算法,该算法从非侵入性方法过渡到侵入性更强的方法。该算法在慢性腹痛和影像学改变不明确的患者中最大限度地提高了特异性(低假阳性率)。此外,建议采用一种命名法,根据TIGAR-O(中毒性、特发性、遗传性、自身免疫性、复发性和阻塞性)病因、腺体形态(剑桥标准)和生理状态(外分泌、内分泌功能)进一步描述确诊的慢性胰腺炎患者,以便在未来的多中心研究合作中保持一致性。本指南将作为一份基础手稿,随着新证据的出现和我们对慢性胰腺炎认识的提高而进行修改。